| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8960752 | Brain, Behavior, and Immunity | 2018 | 32 Pages |
Abstract
In conclusion, this study reveals that interaction of CD200-CD200R1 plays a crucial role in limiting inflammation and lesion progression after SCI, and that boosting the stimulation of this pathway may constitute a new therapeutic approach.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Natalia Lago, Bruno Pannunzio, Jesús Amo-Aparicio, Rubèn López-Vales, Hugo Peluffo,